Edward NirenbergNovavax is now presenting their data. Novavax uses a protein nanoparticle expressed in insect cells, which have truncated glycans. They suspect that this allows more of the spike to be exposed to allow for broader responses.
1/3
1/3
Microbiology Journal ClubSlides # 2, 5, 7, 9, and 10 from a presentation entitled #Data in Support of #Novavax XBB.1.5 #Vaccine. Link at the end of the post.
It presents the recombinant protein particle plus matrix-M #adjuvant. There is data showing the neutralizing responses of serum from vaccinated macaques against #pseudoviruses made with different variant's spikes.
https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2023-09-12/09-COVID-Dubovsky-508.pdf